Niche CDMO Specialized small-to-mid sized GMP CDMO with experience in psychedelics, controlled substances, paediatrics, and niche manufacturing across multiple dosage forms offers targeted outsourcing opportunities for clients seeking compliant, end-to-end development and production.

Global Collaboration Over 150 clients globally and 300+ NCE/microbiome projects indicate strong capacity for diverse programs, enabling cross-sell to existing pharma networks and expansion into related therapeutic areas.

Full-spectrum Services Capabilities span preclinical formulation screening to GMP clinical and commercial manufacturing and clinical trial supply, presenting upsell potential for clients seeking seamless, one-stop development and manufacturing solutions.

Strategic Partnerships Recent alliances and pilot programs with external biotech and mineral/industry players (e.g., Allonnia) signal openness to collaboration models that can be extended to contract manufacturing, tech-enabled solutions, and sustainability-focused projects.

Financial Entry Revenue in the low-to-mid multi-million range with a lean employee base suggests scalable engagement opportunities through tiered service packages, add-on analytical and regulatory support, and expanded pricing for broader capacity utilization.